Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
about
What is known about melatonin, chemotherapy and altered gene expression in breast cancerPreclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.Hypoxia and cellular metabolism in tumour pathophysiology.The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors.Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications.Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer.Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.Role of liver ICAM-1 in metastasis.Cancer initiating-cells are enriched in the CA9 positive fraction of primary cervix cancer xenografts.Protein kinase D2: a versatile player in cancer biology.Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX.Hypoxia and acidosis: immune suppressors and therapeutic targets.Sleep-disordered breathing in patients with newly diagnosed lung cancer.The effect of mast cells on the biological characteristics of prostate cancer cells.Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell lineCombination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cellsBlocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survivalAn overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications
P2860
Q33597963-E3DE8226-1F5C-41E2-B4A2-D635848FB478Q36396832-363D7222-B4D3-4100-A12A-24370A46443FQ37705814-6B79F115-E5D2-4956-87E6-22DEF8C6E2BCQ38772023-1A35522F-0A38-4C11-AAEF-4C73114C05C0Q38930244-35DE74AB-F27D-4A11-982F-63DB8766FD0AQ39197682-5428565B-9DD4-4A6F-83E8-D404B144DA45Q39415253-42CD60E4-BCB4-4166-80F1-A0639BCBB311Q40680671-7D8AE819-0B99-45C6-9219-10673DFE196BQ41666673-9E690927-B3B6-4B41-A1D8-D54C0FE97DA9Q41701847-699AD511-ED0D-459D-AC84-A6C27F8A702DQ42316211-8A0C4D6D-4C0F-4674-AC5A-7BF1F9252B24Q47273020-DAE5686D-E634-4854-8A38-17B7225DAD32Q52362933-4669D222-EAA6-4C5C-86BF-AA7F9E17F20FQ52683574-BE3C5761-E7A6-463E-88BB-AF0C582DF6AAQ55004439-BFB01C82-8704-49EE-BAFF-8BBBE5DEEF93Q55191473-C745D3DC-AF96-461B-AECC-205C06FF8A7AQ58539473-BBF88925-4B1F-42D0-AE9B-12E7B624654AQ58714990-C49794B2-E5B1-4246-81CE-EB03CCC348A4Q58743974-FCE5EB4C-DAE8-46DF-A668-56B47D6CA1D4Q58790007-E6996B05-8112-450B-A38E-B18BB35C1330
P2860
Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@ast
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@en
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@nl
type
label
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@ast
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@en
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@nl
prefLabel
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@ast
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@en
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@nl
P2860
P3181
P356
P1476
Overcoming Hypoxia-Mediated Tu ...... genesis and Immune Dysfunction
@en
P2093
Paul C McDonald
P2860
P3181
P356
10.3389/FCELL.2016.00027
P407
P577
2016-03-31T00:00:00Z